Data is not available at this time.
Tian Chang Group Holdings Ltd. operates as a diversified industrial conglomerate with three distinct business segments. Its core operations include manufacturing e-cigarettes as an original equipment manufacturer (OEM), producing integrated plastic solutions for various industries including automotive and office equipment, and manufacturing medical consumables such as disposable face masks. The company serves a global customer base across Hong Kong, China, the United States, and European markets, positioning itself as a contract manufacturer rather than a brand owner. This diversified approach allows the company to leverage its manufacturing capabilities across multiple sectors while maintaining operational flexibility. The e-cigarette segment operates in a rapidly evolving regulatory environment, while the plastic solutions business serves more established industrial clients, creating a balanced portfolio that mitigates sector-specific risks through its conglomerate structure.
The company generated HKD 539.6 million in revenue for the period but reported a net loss of HKD 13.7 million, indicating margin pressure across its operations. Despite the negative bottom line, the business maintained positive operating cash flow of HKD 35.9 million, suggesting reasonable working capital management. The absence of capital expenditures during the period may indicate a conservative approach to investment or completed capacity expansion in prior periods.
Tian Chang's diluted EPS of -HKD 0.022 reflects challenges in translating revenue into profitability. The company's operating cash flow generation of HKD 35.9 million demonstrates some underlying cash earnings power despite the reported accounting loss. The lack of capital expenditures suggests either efficient utilization of existing assets or deferred investment decisions pending improved market conditions.
The company maintains a strong liquidity position with HKD 129.5 million in cash and equivalents against total debt of HKD 41.9 million, providing a robust financial cushion. This conservative balance sheet structure, with net cash position, offers flexibility to navigate current operational challenges and potential market volatility in its diverse business segments.
Despite reporting a net loss, the company maintained a dividend payment of HKD 0.015 per share, indicating management's confidence in its cash position and commitment to shareholder returns. The diversified business model across e-cigarettes, plastic solutions, and medical products provides multiple potential growth vectors, though current profitability challenges suggest the need for operational improvements.
With a market capitalization of approximately HKD 248 million, the market values the company at roughly 0.46 times revenue, reflecting skepticism about growth prospects and profitability conversion. The low beta of 0.231 suggests the stock exhibits lower volatility than the broader market, possibly due to its small-cap status and diversified industrial exposure.
The company's primary advantages include its diversified manufacturing capabilities across growing sectors and strong balance sheet providing operational flexibility. However, it faces challenges in improving profitability across its segments, particularly in the competitive e-cigarette OEM market and evolving regulatory landscape. The outlook depends on management's ability to enhance operational efficiency and capitalize on demand trends in its target markets.
Company financial reportsHong Kong Stock Exchange filings
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |